Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Tirzepatide activates GIP and GLP-1 receptors in the exocrine pancreas, promoting a reduction in blood glucose levels and aiding in the management of type 2 diabetes (T2D) [1]
Mochi's partner pharmacy follows this practice
By mimicking the action of the glucagon-like peptide-1 (GLP-1), this medication sends strong signals to the brain that modulate hunger cues
Understanding the mechanism helps you appreciate why retatrutide produces different results than tirzepatide and why the transition is worth the effort for the right candidates
US$ 26.95
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 26.72
US$ 27.59
,type=downsize)
